News

How CONCIERGE KEY Health views and pursues value in care.

The potential of new tech, from wearables to telehealth platforms, is undeniable: But how can all this stuff be made both cool and credible?

The new BPCI Advanced covers many of the same interventions that the recently-cancelled mandatory program would have.

In the first part of this interview, the executive describes how clunky scheduling systems are hurting hospitals.

The pharma company and the precision medicine start-up are chasing better cancer care.

Just 2 years ago, Practice Fusion seemed to be headed towards a billion-dollar IPO. Allscripts just bought it for a tenth of that.

While positive behavioral change from wearable usage hasn’t been conclusively demonstrated, the value of the data they produce is indisputable.

Researchers set out to see how holidays, weekends, and time of day affected the use of food-recording smartphone apps.

The pairing comes on the heels of a $30 million fundraising round for the population health analytics firm.

“I think our conference is unique in that we’re focused on more practical applications of artificial intelligence and machine learning."

Excel Medical calls the combined approval of a predictive algorithm and delivery platform "the first of its kind."

How the 2 titans plan to promote precision medicine.

Two groups that control $2 billion worth of Apple stock are urging the company to weigh in on the scientific tug-of-war that surrounds the role of smartphones in mental health.

The initiative is similar to the All of Us program being run by the National Institutes of Health in the United States

These in-depth reads helped guide hospitals through transition, promote innovation, and spotlight threats.

A new study tackles 3 vexing questions: Do humans have genes that enable regeneration, could they be used to fight cancer, and can AI find them?

The bipartisan Veterans E-Health and Telemedicine Support Act was passed by the Senate unanimously this week.

Caltech researchers continue to refine the microscopic device, whose potential continues to grow.

The majority of the new funding comes from Chinese genomics giant iCarbonX.

How Quartet’s use of data and AI is attracting blue-chip investors and board members.

How Michael Christman, PhD, left his mark on genomics and so much more.

A barrage of lawsuits were filed against EHR providers in late 2017. yet another has come to light.

Pharma giant Bristol-Myers Squibb is the newest investor in the genomic testing company.

Why healthcare should carry these lessons into the new year.

Why the cutting-edge analytics firm is joining forces with Baptist Health South Florida's year-old cancer center.

From new partnerships to big paydays, this list focuses on start-ups and mega-companies alike.

The settlement with HHS is hardly the end of 21st Century Oncology's financial and compliance woes.

Before the initiative, the disease had killed 6 men in a mental health facility.